Global Cell Therapy Market (2020 to 2027) – by Cell Type, Therapy Type, Therapeutic…

first_img TAGS  Pinterest By Digital AIM Web Support – March 23, 2021 Twitter WhatsApp Facebook DUBLIN–(BUSINESS WIRE)–Feb 8, 2021– The “Cell Therapy Market by Cell Type, Therapy Type, Therapeutic Area, and End User: Global Opportunity Analysis and Industry Forecast, 2020-2027” report has been added to’s offering. The global cell therapy market accounted for $7,754. 89 million in 2019, and is expected to reach $48,115. 40 million by 2027, registering a CAGR of 25. 6% from 2020 to 2027. Cell therapy involves administration of somatic cell preparations for treatment of diseases or traumatic damages. Cell therapy aims to introduce new, healthy cells into a patient’s body to replace diseased or missing ones. This is attributed to the fact that specialized cells, such as brain cells, are difficult to obtain from human body. In addition, specialized cells typically have a limited ability to multiply, making it difficult to produce sufficient number of cells required for certain cell therapies. Some of these issues can be overcome through the use of stem cells. In addition, cells such as blood and bone marrow cells, mature, immature & solid tissue cells, adult stem cells, and embryonic stem cells are widely used in cell therapy procedures. Moreover, transplanted cells including induced pluripotent stem cells (iPSCs), embryonic stem cells (ESCs), neural stem cells (NSCs), and mesenchymal stem cells (MSCs) are divided broadly into two main groups including autologous cells and non-autologous cells. Development of precision medicine and advancements in Advanced Therapies Medicinal Products (ATMPS) in context to their efficiency and manufacturing are expected to be the major drivers for the market. Furthermore, automation in adult stem cells and cord blood processing and storage are the key technological advancements that fuel growth of the market for cell therapy. In addition, growth in aging patient population, The rise in cell therapy transplantations globally, and surge in disease awareness drive growth of the global cell therapy market. Furthermore, The rise in adoption of human cells over animal cells for cell therapeutics research, technological advancements in field of cell therapy, and increase in incidences of diseases such as cancer, cardiac abnormalities, and organ failure are the key factors that drive growth of the global market. Moreover, implementation of stringent government regulations regarding the use of cell therapy is anticipated to restrict growth of the market. On the contrary, surge in number of regulations to promote stem cell therapy and increase in funds for research in developing countries are expected to offer lucrative opportunities to the market in the future. The global cell therapy market is categorized on the basis of therapy type, therapeutic area, cell type, end user, and region. On the basis of therapy type, the market is segregated into autologous and allogenic. By therapeutics, it is classified into malignancies, musculoskeletal disorders, autoimmune disorders, dermatology, and others. Key BenefitsThe study provides an in-depth analysis of the global cell therapy market along with the current trends and future estimations to elucidate the imminent investment pockets.Comprehensive analysis of factors that drive and restrict the market growth is provided in the report.Comprehensive quantitative analysis of the industry from 2019 to 2027 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.Extensive analysis of the key segments of the industry helps in understanding the forms and types of cell therapy used across the globe.Key market players and their strategies have been analyzed to understand the competitive outlook of the market. Market Dynamics DriversTechnological Advancements in the Field of Cell TherapyThe Rise in Number of Cell Therapy Clinical StudiesThe Rise in Adoption of Regenerative Medicine RestraintDeveloping Stage and Pricing OpportunityHigh Growth Potential in Emerging Markets Companies ProfiledAllosourceCells for CellsHolostem Terapie Avanzate SrlJcr Pharmaceuticals Co. Ltd.Kolon Tissuegene, Inc.Medipost Co. Ltd.Mesoblast LtdNuvasive, Inc.Osiris Therapeutics, Inc.Stemedica Cell Technologies, Inc. For more information about this report visit View source version on CONTACT: Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 KEYWORD: INDUSTRY KEYWORD: HEALTH GENERAL HEALTH SOURCE: Research and Markets Copyright Business Wire 2021. PUB: 02/08/2021 12:53 PM/DISC: 02/08/2021 12:53 PM Twittercenter_img Global Cell Therapy Market (2020 to 2027) – by Cell Type, Therapy Type, Therapeutic Area, and End-user – Local NewsBusiness Pinterest Facebook WhatsApp Previous articleKami Hoss, DDS of The Super Dentists Launches Super Toothbrushes for Kids – Infants to TeensNext articleTrump’s 2nd trial to start with fight over its legitimacy Digital AIM Web Supportlast_img

Leave a Reply

Your email address will not be published. Required fields are marked *